Stocks · Health care · Biological Products, (No Diagnostic Substances)

PRECISION BIOSCIENCES INC

DTIL Clue Score48
United States Fiscal year ends May CIK 0001357874 Results filed 3 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
J. Jefferson Smith
18 Feb 2026
Chief Research Officer
Sold on a plan
4,925
$3.84
$18.91K
Dario Scimeca
18 Feb 2026
General Counsel and Secretary
Sold on a plan
4,925
$3.84
$18.91K
John Alexander Kelly
18 Feb 2026
Chief Financial Officer
Sold on a plan
8,149
$3.84
$31.29K
Michael Amoroso
18 Feb 2026
President and CEO
Sold on a plan
20,559
$3.84
$78.95K
Michael Amoroso
22 Jan 2026
President and CEO
Sold on a plan
34,799
$4.17
$145.11K
John Alexander Kelly
21 Jan 2026
Chief Financial Officer
Sold on a plan
15,213
$4.03
$61.31K
Dario Scimeca
21 Jan 2026
General Counsel and Secretary
Sold on a plan
8,854
$4.03
$35.68K

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 447,933
History held since 29 Mar 2019